Article Text

PDF
Essential thrombocythaemia and its neurological complications
  1. Thomas D Miller1,
  2. Mira H Farquharson2
  1. 1Core Medical Trainee, Division of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, UK
  2. 2Consultant Haematologist, Department of Haematology, Western General Hospital, Edinburgh, UK
  1. Correspondence to Dr M H Farquharson, Department of Haematology, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK; mira.farquharson{at}luht.scot.nhs.uk

Abstract

Essential thrombocythaemia is one of the chronic myeloproliferative neoplasms and is characterised by a sustained platelet count ≥450 × 109/l. The clinical course is often indolent but a significant number of patients have thrombotic and haemorrhagic complications. A patient with neurological complications is described, and the pathogenesis and clinical features of this disease are reviewed, including its neurological sequelae and management, along with an outline for the investigation of patients with thrombocytosis.

Statistics from Altmetric.com

Footnotes

  • Competing interests None.

  • Patient consent Obtained.

  • Provenance and peer review Commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.